Filing Flows › Entera Bio (ENTX) › Q1 2025
Entera Bio (ENTX) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 9, 2025
Entera Bio (ENTX) reported revenue of $42K for the first quarter 2025 (Q1 2025) and -49% from the quarter before.
Entera Bio, Q1 2025: revenue $42K, net loss $2.6M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $42K | -49% | — |
| Operating profit | −$2.6M | — | — |
| Net earnings | −$2.6M | — | — |
| Operating cash flow | −$1.4M | — | — |
What changed
Revenue was $42K in Q1 2025, down 49% from the previous quarter.
Operating costs exceeded revenue by $2.6M, an operating margin of -6102.4%. The quarter ended with a net loss of $2.6M, wider than the previous quarter's $2.4M loss.
Operating cash flow was −$1.4M. Non-cash charges added back $8K of depreciation and $604K of share-based compensation. Working capital and other items added $551K. Capital expenditures of $8K exceeded it, leaving free cash flow of −$1.4M.
Questions
What was Entera Bio's revenue in the first quarter 2025?
Entera Bio (ENTX) reported revenue of $42K for the first quarter 2025 (Q1 2025) and -49% from the quarter before.
Source: Entera Bio 10-Q on SEC EDGAR.